🇺🇸 FDA
Patent

US 11878064

Nanoparticle/peptide method of blocking potassium channels

granted A61KA61K38/17A61K38/1767

Quick answer

US patent 11878064 (Nanoparticle/peptide method of blocking potassium channels) held by The Government of the United States of America, as represented by the Secretary of the Navy expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America, as represented by the Secretary of the Navy
Grant date
Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/17, A61K38/1767, A61K47/52, A61K47/6923